Skip to content
HowShorted

Korro Bio, Inc. short interest in 2022

In 2022, Korro Bio, Inc.'s disclosed short interest ran from 9.44% of shares outstanding on 14 Jan 2022 to 1.20% on 30 Dec 2022, a change of -8.24 percentage points. The year's high was 9.44% on 14 Jan 2022 and its low 1.20% on 30 Dec 2022, averaging 3.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.28 days on 14 Jan 2022. Full history: Korro Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Korro Bio, Inc. in 2022

2022 in figures

Start of year
9.44% (14 Jan 2022)
End of year
1.20% (30 Dec 2022)
Change
-8.24 pp
High
9.44% (14 Jan 2022)
Low
1.20% (30 Dec 2022)
Average
3.35%
Highest days to cover
15.28 (14 Jan 2022)
SEC filings marked
8

Every report in 2022

Korro Bio, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20229.44%15.28
31 Jan 20226.49%8.42
15 Feb 20223.84%6.31
28 Feb 20223.14%4.04
15 Mar 20224.03%3.8710-K filed, results (8-K)
31 Mar 20224.06%4.59
14 Apr 20224.45%1.61
29 Apr 20225.00%1.19
13 May 20225.86%2.5510-Q filed, results (8-K)
31 May 20225.06%3.03
15 Jun 20224.41%3.07
30 Jun 20223.04%1.26
15 Jul 20222.52%1.06
29 Jul 20222.34%3.82
15 Aug 20222.13%3.0210-Q filed, results (8-K)
31 Aug 20222.06%5.22
15 Sep 20221.96%5.47
30 Sep 20221.97%6.83
14 Oct 20221.77%9.37
31 Oct 20221.56%8.45
15 Nov 20221.43%3.6410-Q filed, results (8-K)
30 Nov 20221.41%5.39
15 Dec 20221.26%6.28
30 Dec 20221.20%1.00

See also: Korro Bio, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.